Riskpilot← Back to searchSign inGet full accessHallén Medicinkonsult AB
ABActiveOrg 5568429202Åsdammsvägen 8Tertiary education · NACE 8540Est. 20110 employees
Revenue 2024
SEK 36K
-87% vs 2023
EBITDA margin
-238.9%
-180% vs 2023
Equity ratio
50.5%
Financial strength
Net profit 2024
SEK -86K
-200% vs 2023
| Revenue | SEK 36K | -87% |
| EBITDA | SEK -86K | -180% |
| Net profit | SEK -86K | -200% |
| Total assets | SEK 105K | -46% |
| Equity | SEK 53K | -62% |
| Employees | 0 | — |
Legal name
Hallén Medicinkonsult AB
Org number
5568429202
Legal form
Aktiebolag
NACE code
8540 · Tertiary education
Founded
23 februari 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva läkararbete på sjukhus, inom primärvården samt privat läkarverksamhet. Dessutom ska föreläsningar inom medicin hållas åt högskolor, universitet och privata företag. Rådgivning och konsultarbete inom medicinska områden åt privat- personer och företag.
Address
Åsdammsvägen 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 155 | 307 | 337 | 271 | 36 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 | 142 | 182 | 108 | −86 |
| Depreciation & amort. | −3 | −4 | −3 | −2 | −1 |
| EBIT | 0 | 138 | 179 | 106 | −87 |
| Net financials | — | — | — | — | 1 |
| Profit before tax | 0 | 138 | 179 | 106 | −86 |
| Tax | −0 | −31 | −39 | −20 | −0 |
| Net profit | 0 | 107 | 140 | 86 | −86 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 177 | 219 | 257 | 193 | 105 |
| Equity | 57 | 164 | 194 | 140 | 53 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 120 | 55 | 63 | 53 | 51 |
| Total debt | 120 | 55 | 63 | 53 | 51 |
EBITDA margin
-238.9%
This company
15.8%
Market median
-1612% vs market
20202024
Equity ratio
50.5%
This company
38.2%
Market median
+32% vs market
20202024
Return on equity
-162.3%
This company
18.4%
Market median
-982% vs market
20202024
Net profit margin
-238.9%
This company
8.1%
Market median
-3049% vs market
20202024
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20202024
Debt / equity
0.98×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hallén Medicinkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jennifer Sandra Campbell | Deputy Board Member | 0 companies |
| Åke Tobias Campbell Hallén | Board of Directors | 0 companies |